Screening for Mesothelioma: New French Tool May Help

screening for mesothelioma

Researchers in France say they have come up with a highly accurate way of screening for mesothelioma and lung cancer. 

A new study shows their method, which includes a job history, a questionnaire, and an in-person interview, is 100 percent accurate at identifying people with asbestos cancer.

If it can be confirmed in a larger group of patients, the tool may allow for easier and earlier diagnostic screening for mesothelioma.

The Challenge of Screening for Mesothelioma

Malignant mesothelioma is a fast-growing cancer with a dismal prognosis. Earlier diagnosis might help, but the disease produces few symptoms until it is very advanced. By the time mesothelioma symptoms like chest pain and coughing appear, it is often too late for treatment to do much good.

Malignant mesothelioma is most common in people who have worked around asbestos. Researchers have tried to find ways to screen exposed workers. 

CT scanning may highlight early signs of mesothelioma. But it is also expensive and time consuming, making it impractical for routine screening for mesothelioma. 

A faster, less expensive tool has the potential to improve outcomes and save lives. 

Powerful Three-Part Screening System

Researchers with Raymond-Poincaré Hospital in Garches, France believe they may have developed such a tool. They say their three-part system is an easy and accurate way of screening for mesothelioma.  

They tested the tool on fifty patients hospitalized for either lung cancer or pleural mesothelioma between 2016 and 2017.

Each patient submitted a job history. The information went into job-exposure matrices developed by the researchers. Occupational medicine residents who input the information did not know which disease each patient had. 

The second part was a questionnaire. The third part of the screening for mesothelioma or lung cancer was a one-on-one conversation.

“The patients…had a consultation with a chief resident in occupational medicine, considered the gold standard,” writes lead author Eric Lorentz. 

Accurate Screening for Mesothelioma

The residents who collected the information from patients did not know each patients’ diagnosis in advance. But with the exposure matrices, they identified mesothelioma and lung cancer with 100 percent accuracy.

The asbestos exposure matrices ruled out mesothelioma with 76 percent accuracy. Ruling out a disease – called test sensitivity – is vital for making an accurate mesothelioma diagnosis. 

“The matrices and the questionnaire have a great diagnostic performance which seems interesting for use as a screening tool for occupational exposures.” the team concludes. 

They say a larger study should confirm the method before doctors use it in screening for mesothelioma. 

Source:

Lorentz, E, et al, “[Screening of occupational exposure to asbestos and silica by job-exposure matrix among patients with lung cancer and mesothelioma]”, November 11, 2019, Review of Respiratory Diseases, Epub ahead of print, https://www.sciencedirect.com/science/article/pii/S0761842519303316?via%3Dihub

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…